Navigation Links
Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval
Date:3/3/2009

New Technology Used to Treat Abnormal Heart Rhythms

AUSTIN, Texas, March 3 /PRNewswire/ -- On Tuesday, March 3, 2009, the Texas Cardiac Arrhythmia Institute at St. David's Medical Center became the first in the United States to utilize the long-awaited NaviStar(R) RMT ThermoCool(R) Catheter to treat abnormal heart rhythms, or arrhythmias, since the new technology received FDA approval on Friday, Feb. 27, 2009.

The NaviStar(R) RMT ThermoCool(R) Catheter for radiofrequency (RF) ablation is used with the NIOBE(R) Magnetic Navigation System, which helps steer a catheter remotely and guide ablation to targeted areas that require treatment.

An irregular rhythm in the left upper chamber of the heart or atrial fibrillation is the most common arrhythmia. Like other catheters, the NaviStar(R) RMT ThermoCool(R) Catheter uses heat to destroy abnormal heart muscle that causes atrial fibrillation. The new technology is unique because it sprays cooled saline. Physicians say it is safer and more effective than previous catheters and poses fewer risks for complications.

The NaviStar(R) RMT ThermoCool(R) Catheter maintains a temperature of no more than 42 degrees Celsius while ablation energy is being delivered to the heart tissue. Previously, the temperature at the tip of the catheter reached 65 degrees Celsius, which could cause blood clots on the heart tissue.

"The NaviStar(R) RMT ThermoCool(R) Catheter is revolutionary to the treatment of irregular heart rhythms," said Andrea Natale, M.D., F.A.C.C., F.H.S., executive director of the Texas Cardiac Arrhythmia Institute at St. David's Medical Center and the electrophysiologist who performed the procedure. "The fact that the Texas Cardiac Arrhythmia Institute is the first in the United States to employ this leading-edge technology is proof that we are on the forefront of treatment for heart arrhythmias."

The Texas Cardiac Arrhythmia Institute at St. David's Medical Center (TCAI) is a multi-million dollar international treatment, training and research institute specializing in heart rhythm disorders led by world-renowned electrophysiologist, Andrea Natale, M.D., F.A.C.C.

Arrhythmias are problems that affect the electrical system, or "wiring," of the heart muscle. They are very common and millions of people will experience an abnormal heart rhythm some time during their lives.

Atrial fibrillation (A Fib), known as the "silent killer" because it often goes unnoticed, is a disorder found in roughly 2.2 million Americans. During A Fib, the heart's two small upper chambers (the atria) quiver instead of beating effectively. Blood isn't pumped completely out of them, so it may pool and clot. If a piece of a blood clot in the atria leaves the heart and becomes lodged in an artery in the brain, a stroke results.

The American Heart Association estimates that 20 percent of all strokes result from A Fib and are usually more debilitating due to the larger size of the clots. A person with A Fib has a six-fold increased risk of stroke versus patients with normal heart rhythm. The likelihood of developing A Fib increases with age, affecting roughly three to five percent of people over age 65.

Traditionally, patients diagnosed with A Fib take blood thinning medications to prevent blood clots from forming in the heart. Current blood thinning medications require frequent monitoring and have diet and other drug interactions causing many patients to discontinue use of the medication.

In addition to Natale, the team of electrophysiologists with Texas Cardiac Arrhythmia and TCAI includes Shane M. Bailey, M.D.; J. David Burkhardt, M.D., F.A.C.C.; Robert C. Canby, M.D., F.A.C.C.; Rodney P. Horton M.D.; G. Joseph Gallinghouse, M.D.; Larry D. Price, D.O.; Javier E. Sanchez, M.D.; and Jason D. Zagrodzky, M.D.

The NaviStar(R) RMT ThermoCool(R) Catheter was created by Biosense Webster, a Johnson & Johnson Company.

For more information about the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, visit www.stdavids.com.

For more information about Texas Cardiac Arrhythmia, visit www.TCAheart.com.

    MEDIA CONTACTS:
    Kristin Marcum or Erin Ochoa
    Elizabeth Christian & Associates Public Relations
    512.472.9599


'/>"/>
SOURCE Texas Cardiac Arrhythmia Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Motor behavioral research at UH moves to prestigious Texas Medical Center
2. New Texas Study Reveals Serious Flaws in Abstinence Programs
3. Texas Association of Health Underwriters Announces 15th Annual Day at the Capitol
4. Partnership for Prescription Assistance Prepared to Help Texas Workers Hurt by Recession
5. University of Texas engineers receive $3.2 million in National Science Foundation CAREER awards
6. Accordent Delivers Medical Lecture Capture Platform for University of Texas Health Sciences Center
7. Texas Mutual Wins National Employee Wellness Award
8. New Research Study in Houston, Texas Seeks Improved Quality of Life for People in the Future with Schizophrenia
9. Texas Health Dallas New Intensivist Program Puts Critical-Care Specialists in the ICU - All the Time
10. High-tech Texas hospitals see fewer complications, lower costs, UT Southwestern researcher finds
11. Texas Tech University Health Sciences Center and AMD Global Telemedicine Inc. Expand Telemedicine Program Throughout Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of ... a new solution for Emergency Departments (ED) has been added to their portfolio. ... Department examination rooms, and with a simplified pallet of information available to the ...
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
(Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
Breaking Medicine Technology: